Nomikos GG - Search Results

1

CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action.

Degroot A, Köfalvi A, Wade MR, Davis RJ, Rodrigues RJ, Rebola N, Cunha RA, Nomikos GG. Degroot A, et al. Among authors: nomikos gg. Mol Pharmacol. 2006 Oct;70(4):1236-45. doi: 10.1124/mol.106.024661. Epub 2006 Jul 19. Mol Pharmacol. 2006. PMID: 16855179

2

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.

Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP, Witkin JM, Nomikos GG. Tzavara ET, et al. Among authors: nomikos gg. Br J Pharmacol. 2003 Feb;138(4):544-53. doi: 10.1038/sj.bjp.0705100. Br J Pharmacol. 2003. PMID: 12598408 Free PMC article.

3

Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action.

Tzavara ET, Wade M, Nomikos GG. Tzavara ET, et al. Among authors: nomikos gg. J Neurosci. 2003 Oct 15;23(28):9374-84. doi: 10.1523/JNEUROSCI.23-28-09374.2003. J Neurosci. 2003. PMID: 14561865 Free PMC article.

4

Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide.

Degroot A, Wade M, Salhoff C, Davis RJ, Tzavara ET, Nomikos GG. Degroot A, et al. Among authors: nomikos gg. Eur J Pharmacol. 2004 Jun 16;493(1-3):103-9. doi: 10.1016/j.ejphar.2004.04.011. Eur J Pharmacol. 2004. PMID: 15189770

5

Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test.

Degroot A, Nomikos GG. Degroot A, et al. Among authors: nomikos gg. Eur J Neurosci. 2004 Aug;20(4):1059-64. doi: 10.1111/j.1460-9568.2004.03556.x. Eur J Neurosci. 2004. PMID: 15305874

6

Genetic deletion of CB1 receptors improves non-associative learning.

Degroot A, Salhoff C, Davis RJ, Nomikos GG. Degroot A, et al. Among authors: nomikos gg. Behav Brain Res. 2005 Jul 1;162(1):161-4. doi: 10.1016/j.bbr.2005.02.018. Epub 2005 Mar 17. Behav Brain Res. 2005. PMID: 15922076

7

Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine.

Wade MR, Nomikos GG. Wade MR, et al. Among authors: nomikos gg. Psychopharmacology (Berl). 2005 Nov;182(3):393-9. doi: 10.1007/s00213-005-0106-4. Epub 2005 Oct 19. Psychopharmacology (Berl). 2005. PMID: 16075289

8

Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying model.

Degroot A, Nomikos GG. Degroot A, et al. Among authors: nomikos gg. Eur J Pharmacol. 2006 Feb 15;531(1-3):183-6. doi: 10.1016/j.ejphar.2005.12.036. Eur J Pharmacol. 2006. PMID: 16455072

9

Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents.

Wade MR, Degroot A, Nomikos GG. Wade MR, et al. Among authors: nomikos gg. Eur J Pharmacol. 2006 Dec 3;551(1-3):162-7. doi: 10.1016/j.ejphar.2006.08.083. Epub 2006 Sep 12. Eur J Pharmacol. 2006. PMID: 17030030

10

CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors.

Tzavara ET, Degroot A, Wade MR, Davis RJ, Nomikos GG. Tzavara ET, et al. Among authors: nomikos gg. Eur Neuropsychopharmacol. 2009 Mar;19(3):196-204. doi: 10.1016/j.euroneuro.2008.11.003. Epub 2008 Dec 29. Eur Neuropsychopharmacol. 2009. PMID: 19116182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters